Endonovo Therapeutics (ENDV) News Today → Collapse of the Petrodollar (From Colonial Metals) (Ad) Free ENDV Stock Alerts $0.0015 0.00 (0.00%) (As of 05/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineNeurAxis (NASDAQ:NRXS) vs. Endonovo Therapeutics (OTCMKTS:ENDV) Critical Comparisonamericanbankingnews.com - May 8 at 1:54 AMEndonovo Closes Asset Purchase Agreement for a Minimum of $50M With SofPulse, Incglobenewswire.com - March 28 at 9:03 AMEndonovo’s SofPulse® to Be Featured at Innovative Pain Management Solutionsfinance.yahoo.com - March 4 at 1:06 PMEndonovo's SofPulse® to Be Featured at Innovative Pain Management Solutionsglobenewswire.com - March 4 at 9:09 AMEndonovo Signs Definitive Agreement to Sell SofPulse® Brand Business and IP to SofPulse Inc. for a minimum of $50 Millionfinance.yahoo.com - December 4 at 12:48 PMEndonovo Therapeutics, Inc. (ENDV)finance.yahoo.com - November 21 at 6:56 PMLexeo Therapeutics Inc (LXEO)investing.com - November 15 at 2:10 PMEndonovo receives Taiwanese approval for SofPulse technologymsn.com - October 13 at 12:28 PMEndonovo's SofPulse® Secures Taiwan FDA Approvalfinance.yahoo.com - October 12 at 10:51 AMEndonovo’s SofPulse® Secures Federal Supply Schedule Inclusion to Accelerate Expansion of VA Distributionfinance.yahoo.com - August 22 at 9:24 AMEndonovo’s Breaking Barriers in With Patented Medical Technologies: 2023 Bi-Annual Updatefinance.yahoo.com - August 8 at 12:48 PMNew to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.finance.yahoo.com - June 22 at 2:45 PMNew to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.finance.yahoo.com - June 22 at 2:45 PMEndonovo Pending Agreement to Develop Telehealth Divisionfinance.yahoo.com - June 7 at 10:30 AMEndonovo Launches SofPulse® into the Veterans Administrationfinance.yahoo.com - May 2 at 12:56 PMEndonovo Reaches Out to Top Clinical Researchers to Collaborate on TBI Treatment Studiesfinance.yahoo.com - April 25 at 1:38 PMEndonovo Announces Partnership with Former NFL Dallas Cowboy Defensive Linemanfinance.yahoo.com - April 13 at 10:55 AMEndonovo Announces Partnership with Santana Lead Singer Andy Vargasfinance.yahoo.com - April 10 at 4:13 PMEndonovo Announces Binding Letter of Intent to Sell SofPulse® Assets to Spin-Off Companyfinance.yahoo.com - March 29 at 12:50 PMEndonovo’s SofPulse® Nears Final Stages to Receive Taiwan FDA License to Distribute in Taiwanfinance.yahoo.com - March 23 at 1:01 PMOlympian and Champion Surfer Carlos Muñoz Turns To SofPulse® For Accelerated Recovery After Invasive Shoulder Surgeryfinance.yahoo.com - March 15 at 1:21 PMEndonovo Therapeutics (OTCMKTS:ENDV) Reaches Distribution Agreement with Academy Medicalfinance.yahoo.com - March 9 at 7:42 AMEndonovo Announces Distribution Agreement with Academy Medicalfinance.yahoo.com - March 6 at 10:14 AMEndonovo Announces Q&A with Newly-Appointed SofPulse® Medical Division President, Ira Weisbergfinance.yahoo.com - February 28 at 10:39 AMEndonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Offfinance.yahoo.com - January 31 at 10:12 AMEndonovo Partners with International Distributor for SofPulse® Linefinance.yahoo.com - January 26 at 9:54 AMENDV.PK - | Stock Price & Latest News | Reutersreuters.com - January 23 at 7:36 PMNew Details on Endonovo’s Spin-Off of SofPulse, Inc.finance.yahoo.com - January 19 at 1:41 PMEndonovo Therapeutics Details Plan to Spin Off Medical Device Division as a Listed Public Companyfinance.yahoo.com - January 9 at 12:18 PMEndonovo Targets Dept. of Defense, VA & Federal Contractsfinance.yahoo.com - January 3 at 12:21 PMEndonovo Announces Advancement of International “Go to Market” Initiativefinance.yahoo.com - December 19 at 1:55 PMEndonovo Announces Plans for Spin-off of Medical IP and Assetsfinance.yahoo.com - December 15 at 10:18 AMEndonovo Launches Telehealth Initiativefinance.yahoo.com - December 13 at 4:53 PMEQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports Third Quarter 2022 Financial Results and Highlights Operational Progressmarkets.businessinsider.com - November 22 at 4:45 AMENDONOVO ANNOUNCES PLAN TO EXPLORE STRATEGIC ALTERNATIVES FOR ITS SOFPULSE® MEDICAL DEVICE ASSETSfinance.yahoo.com - November 17 at 1:48 PMEndonovo Therapeutics Issues Corporate Updatefinance.yahoo.com - November 7 at 10:48 AMAcrivon Therapeutics sets IPO price rangemsn.com - November 3 at 10:35 PMEQS-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reports H1 2022 Financial Results and Highlights Operational Progressmarkets.businessinsider.com - September 30 at 1:40 PMEndonovo Therapeutics Signs Definitive Asset Purchase Agreement to Acquire A Highly Profitable Texas Concrete Construction Companyfinance.yahoo.com - September 27 at 2:56 PMEndonovo Therapeutics Releases Comparative Analysis Demonstratingfinance.yahoo.com - July 28 at 1:58 PMStranger Things season 4 could have been even longer without the pandemicyahoo.com - July 23 at 8:59 AMDiagnostics Demystified By New "It’s Not Magic, It’s Diagnostics" Campaignnz.finance.yahoo.com - July 23 at 8:59 AMEndonovo Therapeutics Releases A Comparative Analysis Addressing Limitations Of Non-Opioid Pharmaceutical Interventions on the Reduction of Opioid/Narcotic Use For Post-Surgical Pain Managementfinance.yahoo.com - July 21 at 4:06 PMEndonovo Therapeutics Announces LOI to Acquire Specialty Construction Companyfinance.yahoo.com - June 9 at 6:02 PMEndonovo Therapeutics Signs Agreement with NAMSA to Develop Reimbursement Strategy for Endonovo Medical Productsfinance.yahoo.com - April 25 at 1:47 PM$5 Million Common Stock Offering for Endonovo Therapeutics Designed to Advance SofPulse® Process for Medical Reimbursementfinance.yahoo.com - April 11 at 12:27 PMEndonovo Therapeutics Inc ENDVmorningstar.com - March 3 at 7:58 PMEndonovo Therapeutics Inc. (ENDV) Appoints Garry Michael Kann As Head of Corporate Development To Identify And Acquire Profitable Companies For Endonovofinance.yahoo.com - March 1 at 4:43 PMVerity Pharmaceuticals™ and Helsinn Therapeutics sign exclusive agreement for the promotion of Akynzeo® and Valchlor® in Puerto Ricobenzinga.com - February 17 at 6:57 PMEndonovo Therapeutics Issues Shareholder Updatefinance.yahoo.com - October 12 at 7:04 PM Get Endonovo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENDV and its competitors with MarketBeat's FREE daily newsletter. Email Address Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run. Click here now to get your copy. ENDV Media Mentions By Week ENDV Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENDV News Sentiment▼-0.710.58▲Average Medical News Sentiment ENDV News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENDV Articles This Week▼10▲ENDV Articles Average Week Get Endonovo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENDV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: TIVC News Today HSDT News Today MICR News Today NUWE News Today AKAN News Today GNWSF News Today SCNI News Today ACOR News Today EVFM News Today RSPI News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ENDV) was last updated on 5/12/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss RatingsCollapse of the Petrodollar Colonial MetalsHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe Exchange[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICMissed NVDA? Buy this AI stock NOWChaikin AnalyticsYou need to know these two things about AI stocks ASAP…InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Endonovo Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
